• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用于肠胃外给药的缓释药物制剂。第二部分。注射用微球和植入剂]

[Prolonged-release drug formulations for parenteral administration. Part II. Microspheres and implants for injection].

作者信息

Płaczek Margin, Jacyna Julia, Sznitowska Małgorzata

出版信息

Pol Merkur Lekarski. 2014 Jan;36(211):54-8.

PMID:24645581
Abstract

Microspheres and implants are injectable drug forms, which by special design and selection of appropriate excipients, provide for a long time constant release rate of an active substance in the body. Development of both would not be possible without advances in polymer technology and invention of safe and biocompatible polymers such as: polyesters, vinyl acetate derivatives or silicones. Polymeric matrices provide retardation of drug release--for some implants up to a few years. In addition, this paper presents examples of all commercially available medicinal products containing microspheres and implants, currently registered in Poland, together with their characteristics: composition, time course and frequency of administration. Comments are also enclosed on frequently occurring inconsistent terminology in pharmaceutical forms.

摘要

微球和植入剂是可注射的药物剂型,通过特殊设计和选择合适的辅料,可使活性物质在体内长时间以恒定速率释放。如果没有聚合物技术的进步以及安全且生物相容性良好的聚合物(如聚酯、醋酸乙烯酯衍生物或硅酮)的发明,这两种剂型的开发都将无法实现。聚合物基质可延缓药物释放——对于某些植入剂而言,长达数年。此外,本文还列举了目前在波兰注册的所有含有微球和植入剂的市售药品实例及其特性:组成、给药时间过程和频率。文中还对药物剂型中常见的不一致术语进行了评论。

相似文献

1
[Prolonged-release drug formulations for parenteral administration. Part II. Microspheres and implants for injection].[用于肠胃外给药的缓释药物制剂。第二部分。注射用微球和植入剂]
Pol Merkur Lekarski. 2014 Jan;36(211):54-8.
2
[Prolonged-release drug formulations for parenteral administration. Part l. Suspensions and oily solutions for injection].
Pol Merkur Lekarski. 2013 Dec;35(210):391-6.
3
Current advances in sustained-release systems for parenteral drug delivery.用于肠胃外给药的缓释系统的当前进展。
Expert Opin Drug Deliv. 2005 Nov;2(6):1039-58. doi: 10.1517/17425247.2.6.1039.
4
[The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].[天然及合成亲水性聚合物在不同释放曲线盐酸二甲双胍片制剂中的应用]
Polim Med. 2012;42(3-4):167-84.
5
Manufacturing techniques and excipients used during the design of biodegradable polymer-based microspheres containing therapeutic peptide/protein for parenteral controlled drug delivery.用于设计含治疗性肽/蛋白质的可生物降解聚合物基微球以实现肠胃外控释给药的制造技术和辅料。
PDA J Pharm Sci Technol. 2008 Mar-Apr;62(2):125-54.
6
Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release.用于眼内缓释的维生素A棕榈酸酯和阿昔洛韦可生物降解微球。
Int J Pharm. 2006 Dec 1;326(1-2):100-6. doi: 10.1016/j.ijpharm.2006.07.010. Epub 2006 Jul 14.
7
In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting.与非肠道缓释制剂相关的体外和体内考量:基于2007年控释协会年会所呈现的信息及观点的综述
J Control Release. 2008 Jul 14;129(2):79-87. doi: 10.1016/j.jconrel.2008.04.004. Epub 2008 Apr 18.
8
Clinically established biodegradable long acting injectables: An industry perspective.临床认可的可生物降解长效注射剂:行业视角
Adv Drug Deliv Rev. 2020 Dec;167:19-46. doi: 10.1016/j.addr.2020.11.008. Epub 2020 Nov 14.
9
Use of chitosan and hydroxypropylchitosan in drug formulations to effect sustained release.
Drug Des Deliv. 1986 Nov;1(2):119-30.
10
Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.可生物降解的聚合物微球作为疫苗佐剂和递送系统。
Dev Biol Stand. 1998;92:63-78.